Recommendation
- https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567Mayo ClinicNonalcoholic fatty liver disease - Symptoms and causes - Mayo ClinicApr 4, 2024 ... NAFLD ranges in severity from hepatic steatosis, called fatty liver, to a more severe form of disease called nonalcoholic steatohepatitis (NASH) ...
- https://www.niddk.nih.gov/health-information/liver-disease/nafld-nashNational Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic Fatty Liver Disease (NAFLD) & NASH - NIDDKDefinition & Facts. Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. Nonalcoholic fatty liver (NAFL) and ...
- https://www.nature.com/articles/nrgastro.2017.109Global burden of NAFLD and NASH: trends, predictions, risk factors ...Sep 20, 2017 ... NAFLD is one of the most important causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming ...
- https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-factsNational Institute of Diabetes and Digestive and Kidney DiseasesDefinition & Facts of NAFLD & NASH - NIDDKNAFLD (also referred to as metabolic dysfunction-associated steatotic liver disease, or MASLD), is a condition in which excess fat builds up in your liver.
- https://pubmed.ncbi.nlm.nih.gov/31279902/PubMedThe global epidemiology of NAFLD and NASH in patients with type ...This study provides the global prevalence rates for NAFLD, NASH, and advanced fibrosis in patients with T2DM.
- https://www.sciencedirect.com/science/article/pii/S0168827817322821Genetics and epigenetics of NAFLD and NASH: Clinical impact ...The premise for this review is to discuss the status of research into important genetic and epigenetic modifiers of NAFLD progression.
- https://pubmed.ncbi.nlm.nih.gov/29844588/PubMedNoninvasive biomarkers in NAFLD and NASH - current progress ...Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is the most common chronic liver disease worldwide.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953348/PubMed Central (PMC)Emerging Role of Nuclear Receptors for the Treatment of NAFLD ...... NAFLD and NASH. The TZDs rosiglitazone and pioglitazone were tested in ... Abbreviations. NAFLD, Non-Alcoholic Fatty Liver Disease; NASH, Non-Alcoholic ...
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6365925/PubMed Central (PMC)The role of the microbiome in NAFLD and NASH - PMCIn this review, we will explore the impact of gut microbiota and microbiota‐derived compounds on the development and progression of NAFLD and NASH.
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126848GSE126848Non-alcoholic fatty liver disease (NAFLD) ... The hepatic molecular events underlying the development of NAFLD and transition to NASH are poorly understood.
Recommend
All Categories
Others
Privacy Policy
Terms of Use
We scour the internet for answers to just about everything - from finding the latest kitchenware to finding
the best travel destinations.
A unique Q&A structure provides you with relevant information in a quick-read, easy-to-use format. With the
most common questions answered in this format, you're sure to find what you're looking for.
Copyright © 2024 Seahia. All rights reserved